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INTRODUCTION
Varicose  veins  affect  20–30%  of  adults.  People  with  venous 
insufficiency maysuffer  from heaviness,  aching,  throbbing, itching and 
cramps  or  fatigue  in  the  legs.  In  some  patients,  chronic  venous 
insufficiency can lead to skin discoloration,inflammatory dermatitis and 
skin ulceration.
Conservative methods such as compression hosiery may improve 
symptomatic  varicose  veins.  If  symptoms  persist,  the  main  treatment 
options are sclerotherapy,surgery (usually  stripping and ligation of  the 
long or short saphenous veins and phlebectomies), and ablation (by laser 
or radiofrequency ablation). 
Treatment  of  venous  insufficiency  with  liquid  sclerotherapy  is 
considered by some to be an unfulfilled promise . It was heralded in the 
first  half  of  the  last  century  to  be   a  replacement  for  surgery  but  as 
recurrences of varicose veins appeared in limbs  treated with injection 
techniques, surgery re-appeared and was dominant in the last  half of the 
century . Administration of foamed sclerosant  was reintroduced in the 
early 1990s by Cabrerra, who summarized a broad experience in 1997 .
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Foam in sclerotherapy must  be looked upon as  an entirely  new 
method of treatment. Ultrasound-guided foam sclerotherapy for varicose 
veins is a variation of liquid sclerotherapy in which sclerosant foam is 
injected into the affected veins using ultrasound monitoring. The foam 
causes  inflammation  of  the  vein  wall,  leading  to  obliteration  and 
occlusion of its lumen.
It is useful in all types of varices and it is proven to be safe, simple, 
cheap, reliable and repeatable.  it is a potentially useful treatment for both 
main trunk and minor vein disease, and can be conducted as an outpatient 
procedure without the requirement  for  general  or  regional  anaesthesia. 
This could have implications in terms of releasing theatre time and space 
for  other  surgical  procedures.  In  addition,  foam sclerotherapy  can  be 
delivered  in  an  outpatient  setting,  and  possibly  also  a  primary  care 
setting,  as  long  as  the  surgeon  is  appropriately  trained  and  adequate 
diagnostic and monitoring facilities are available.
This work consists of a detailed study of 50 patients with varicose 
veins who were admitted in  Govt. Rajaji Hospital , Madurai, between 
2006 and 2007.
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AIM OF THE STUDY
1. To compare the efficacy of treatment of  varicose veins with 
Saphenofemoral ligation and Foam sclerotherapy compared to 
Saphenofemoral  ligation and stripping.
2. To analyze the merits and demerits of  Foam sclerotherapy.
3. To study the complications following Foam sclerotherapy.
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                                         ANATOMY
The peripheral venous system functions both as a reservoir to hold 
extra blood and  as a conduit to return blood from the periphery to the 
heart and lungs.  Unlike arteries, which possess three well-defined layers, 
most veins are composed  of a  single tissue layer. Only the largest veins 
possess internal  elastic  membranes,  and  at  best  this layer  is  thin and 
unevenly  distributed,  providing  little  buttress  against  high  internal 
pressures. The correct functioning of the venous system  depends on a 
complex series of valves and pumps that are individually frail and  prone 
to  malfunction.
The Superficial Venous System 
The  superficial  venous  system  is  extremely  variable  weblike 
network of  interconnecting veins,  most  of which are unnamed.  A few 
larger  truncal  superficial  veins  are  fairly  constant  in  location;  These 
truncal superficial veins serve as a conduit to pass blood centrally and 
eventually into the deep venous system. 
The principal named superficial veins of the lower extremity are 
the short  saphenous vein (SSV), which usually runs from ankle to knee, 
and the greater  saphenous vein (GSV), which usually runs from ankle to 
groin.
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Anatomy of the Short Saphenous Vein 
The short saphenous vein originates in the lateral foot.  It  passes 
posteriorly  lateral  to  the  Achilles  tendon  in  the  lower  calf.  The  SSV 
usually lies directly above the deep fascia in the midline as it reaches the 
upper calf, where it enters the popliteal space between the two heads of 
the  gastrocnemius  muscles.  In  two  thirds  of  cases,  it  joins  the  deep 
popliteal vein above the knee joint, and in one third of cases, it joins with 
other veins (most often the GSV or the deep muscular veins of the thigh). 
 
Anatomy of the Greater Saphenous Vein 
The GSV originates in the medial foot and passes upward anterior 
to  the  medial  malleolus,  then  crosses  the  medial  tibia  in  a  posterior 
direction to ascend in the medial line across the knee. Above the knee it 
continues  anteromedially  above the  deep  fascia  to  the  thigh,  where  it 
passes through the foramen ovale and joins the (deep) common femoral 
vein at the groin crease.
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SUPERFICIAL VENOUS SYSTEM
11
Tributaries at the  Sapheno femoral junction
1. AL- Anterolateral
2. PM- Posteromedial
3. SEP- Superficial external pudendal
4. SCI- superficial circumflex iliac
5. SE – Superficial epigastric
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Perforating Vein
The SPJ and SFJ are not the only pathways from the superficial 
system  the  deep system.  Both  the  superficial  collecting  web and the 
superfici  truncal  veins  are  also  connected  to  a  variable  number  of 
perforating veins that pass through anatomic defects in the deep fascia to 
join directly with the deep veins of the calf or thigh. Perforating veins 
usually contain venous valves that prevent reflux of blood from the deep 
veins  into  the  superficial  system.  A few named  perforating  veins  are 
fairly constant in location and are named only as vague groupings. 
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The Deep Venous System 
All venous blood eventually is received by the deep venous system 
on its way back to the right atrium of the heart. In most cases there are 
five major named branches to the deep venous system, three below and 
two above the knee.
Deep Veins of the Calf 
In the lower leg, three groups of deep vein exist: the anterior tibial 
vein (ATV),  draining the dorsum of  the foot;  the posterior  tibial  vein 
(PTV),  draining  the  lateral   aspect  of  the  foot.  From  the  ankle,  the 
anterior  tibial  vein  passes  upward  anterolateral  to  the  interosseous 
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membrane,  the  posterior  tibial  vein  passes  upward  posteromedially 
beneath  the  medial  edge  of  the  tibia,  and  the  peroneal  vein  passes 
upward  posteriorly  through the  calf.  Venous  sinusoids  within  the  calf 
muscle coalesce to form soleal and gastrocnemius intramuscular venous 
plexi, which join  the peroneal vein in midcalf. In most patients, each one 
of these is actually a pair  of veins flanking an artery of the same name; 
thus there are actually six named  deep veins below the knee in a typical 
patient. Just below the knee, the four anterior and posterior tibial veins 
join with the two peroneal veins to become the single large popliteal vein
Deep Veins of the Thigh 
The popliteal  vein courses proximally  behind the knee and then 
passes anteromedially in the distal thigh through the adductor canal, at 
which point it is called the FV.The common femoral vein (CFV) passes 
upward above the groin crease to become the iliac vein.
The Calf Muscle Pump .
The passage of blood upward from the feet against gravity depends 
on a complex array of valves and pumps. Muscle pumps of the calf and 
thigh provide the motive force for venous return. The most important of 
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these is called the calf muscle pump, often referred to as the peripheral 
heart. Each segment of the calf muscle pump works in the same way as 
the hand bulb of the sphygmomanometer. Inflow to a segment of deep 
vein is through intake valves from perforating veins as well as from the 
deep vein segment below. Outflow is through an outflow valve to the 
deep vein segment above. Squeezing of the vein segment occurs when 
muscle  contraction  increases  the  pressure  within  a  fascial  muscle 
compartment.
 Pathophysiology
Venous pathology develops when venous return is impaired for any 
reason. Venous pathology can be deep, superficial, or mixed. It can result 
from primary  muscle pump failure, from venous obstruction (thrombotic 
or nonthrombotic), or  from venous valvular incompetence, which may be 
segmental  or  whole leg When  the entire  venous system is  filled,  the 
valves float open and venous pressure rises  to a maximum exactly equal 
to the height of the standing column of venous blood from head to foot. 
This condition triggers an urge to move the legs, activating the muscle 
pumps and re-emptying the legs.
Deep Vein Obstruction 
Partial  obstruction  of  the  deep  veins  may  have  little  effect  on 
venous  outflow,  but  severe  obstruction  of  the  deep  veins  produces 
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secondary muscle pump failure. In  this case the muscle pump produces 
an  appropriately  high  outflow pressure  with  each  contraction,  but  the 
volume of venous blood pumped out of the calf is  reduced because of the 
reduced diameter of the outflow tract. 
Deep Vein Incompetence 
If outflow tracts are open and the muscle pump is functional but 
the valves of the deep veins permit reflux (because of primary agenesis, 
prior  thrombosis,  direct   trauma,  or  dilatation with secondary  valvular 
failure), venous blood will be  pumped out of the calf in normal volumes 
but  extremity  refill  will  include  both   normal  arterial  inflow  and 
pathologic  venous  retrograde  flow.  The  venous  pressure  immediately 
after ambulation may be slightly elevated or it may even be  normal, but 
the veins will  refill  and dilate very quickly.  After  a person with deep 
incompetence stands for only a few seconds, the venous pressure will be 
nearly as high as the maximum reached after prolonged standing. Again, 
the  volume  of  venous  blood  that  suffuses  the  extremity  and  dilutes 
arterial  inflow will  be  somewhat  increased.  A smaller  fraction  of  the 
extremity's  venous  blood  will  return  to  the  central  circulation  each 
minute, and because arterial blood must flow into congested tissues with 
elevated hydrostatic pressure, the volume of arterial inflow will again be 
somewhat reduced. 
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Perforator Incompetence 
Under  ordinary  circumstances  the  bulk  of  venous  blood  moves 
strictly from the superficial to the deep system. Failure of the valves of 
communicating perforator  veins can permit a significant volume of blood 
to flow from deep veins backward  into the superficial system, producing 
local  congestion  and  venous  hypertension.  More  important,  perforator 
incompetence allows the extremely high pressures generated within deep 
veins by the calf muscle pump to be communicated to the  superficial 
veins,  which are not  strong enough to tolerate the pressure.  This  high 
pressure (even if intermittent and highly localized) can produce excessive 
venous  dilatation and secondary failure of superficial vein valves. This is 
one of the major mechanisms for the development of superficial venous 
incompetence and varicose veins. 
Superficial Incompetence 
Superficial  venous  incompetence  is  the  most  common  form  of 
venous disease. Retrograde flow through the superficial venous system 
occurs when venous valve no longer perform their usual function. This 
can happen for a variety of reasons. Direct injury or superficial phlebitis 
may  cause  primary  valve  failure.  In  most  cases,  however,  superficial 
venous reflux is simply the inevitable end result of the introduction of 
high pressures into otherwise normal superficial veins that were intended 
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to  function  as  a  low-  pressure  system.  High  pressure  causes  normal 
superficial veins to dilate so widely that the thin flaps of venous valves 
simply no longer meet in the midline.
High  pressure  can  enter  the  superficial  veins  by  failure  of  key 
valves at any point of communication between the deep and superficial 
systems.  Two  clinical  syndromes  of  high  pressure  superficial  system 
disease  are  recognized:  junctional  and  perforator.  Junctional  high-
pressure disease results from failure of the primary valve at the junction 
between the GSV and the CFV (the SFJ), or at the junction between the 
SSV and  PV (the  SPJ).  Vein  dilatation  in  these  cases  proceeds  from 
proximal  to distal,  and patients  perceive that  a large vein is  "growing 
down to the leg." Perforator high-pressure disease results from failure of 
the valves of any perforating vein. The most common sites of primary 
perforator  valve failure  are at  the canal  of Hunter  in the midproximal 
thigh  (Hunterian  vein)  and in  the  proximal  calf.  If  the  primary  high-
pressure entry point is distal, patients experience the initial development 
of large clusters of veins in the lower leg, with large veins eventually 
"growing up the leg" toward the groin. 
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ANATOMY
Superficial venous 
system
Perforator system of 
communicating veins
Deep venous system
long saphenous vein: 
• runs from the 
medial side of the 
dorsal venous arch 
up the 
anteromedial 
aspect of the leg 
and thigh until it 
empties into the 
femoral vein 
• these veins pass 
through the deep 
fascia and carry 
blood from the 
superficial venous 
system to the deep 
venous system, one 
way flow maintained 
by valves 
• however these valves 
may become 
• comprises 
• femoral and popliteal 
veins 
• venae comitantes ie 
veins accompanying the 
ant. tibial, post. tibial 
and peroneal arteries 
•  valveless blood lakes 
within calf muscle
• communicates with 
superficial system via 
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short saphenous vein 
• runs from the lateral 
side of the dorsal 
venous arch up the 
posterolateral aspect 
of the calf until it 
passes through the 
popliteal fascia 
behind the knee and 
empties into the 
popliteal vein just 
above the knee
incompetent and 
cause appearance of 
superficial varicose 
veins during exercise 
 
a. saphenofemoral 
junction 
b. mid-thigh perforators
c. short sapheno-popliteal 
junction 
d. calf perforators
 
   
PATHOPHYSIOLOGY AND CLINICAL FEATURES
There is a familial tendency toward development of varicose veins. 
In  clinical  practice,  usually  70%  of  patients  can  identify  superficial 
venous  disease  as  a  familial  trait.  In  addition,  the  severity  of  venous 
disease  may  also  be  familial.  Patients  whose  parents  had  venous 
ulceration are at increased risk of this complication as well. 
Female   hormonal   influences  on  the  veins  are  profound.  For 
example,  when  Varicose   veins  develop  in  pregnancy,  in  70-80% of 
cases,  they   appear   in   the  first   trimester.  This  development  is  not 
dependent upon size of the gravid uterus,  increased blood flow, or iliac 
venous occlusion, but is due to the immediate rise of progesterone. It has 
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been found that diameter of the femoral vein increases by  50% within six 
weeks of the start of pregnancy. 
Two forces  act  on the  hereditary/hormonal  substrate  to  produce 
dilation and elongation of veins. The first, the weight of the blood column 
from the right  atrium to the affected veins is  a constant  gravitational 
force and may be referred to  as hydrostatic pressure. This is measured in 
millimeters of water. The Basle study demonstrated that among workers 
in a factory, those with standing jobs were significantly more likely to 
have venous disease, followed by those with sitting  jobs. The adoption of 
a regular exercise program is followed by a reduction in the symptoms of 
aching and pain.  The second is pressure exerted by contracting muscles 
on  adjacent  veins.  This  may.  be  called  a  hydrodynamic  force.  This 
pressure,  measured  in  millimeters  of  mercury  (13  times  heavier  than 
water)  propels  blood  through  open  deep  valves  toward  the  heart. 
However, when valves in perforating veins fail, this force is exerted on 
subcutaneous veins and venules in the epidermis in a pulsatile fashion 
coincident with muscular contraction. It is no wonder that they become 
elongated and tortuous and that venous dilation causes their valves to fail 
in turn.  In summary, it follows that telangiectasias, reticular varicosities, 
and  varicose  veins  are  derived  from  a  hereditary/hormonal  substrate 
which  is  acted  upon  by  static  gravitational  pressure  and  dynamic 
22
muscular forces transmitted through failed venous valves. While neither 
the hereditary nor the hormonal substrate can be altered by intervention, 
the  influence  of  hemodynamic  forces  and hydrostatic  pressure  can  be 
modified by intervention.
Chronic venous insufficiency/venous ulcers
CVI is manifested by lower limb oedema and lipodermatosclerosis, 
i.e.  skin  changes  such  as  pigmentation,  atrophy  and eczema.  It  arises 
secondary to venous  hypertension. The high pressure leads to oedema 
and leakage of protein has local  inflammatory effects.
A chronic venous ulcer can be defined as an area of discontinuity 
of epidermis, persisting for four weeks or more and occurring as a result 
of venous hypertension  and calf muscle pump insufficiency. It is easily 
recognised  when  it  is  situated  in  the  'gaiter'  region  near  the  medial 
malleolus  (the  protuberance  at  the  lower  end   of  the  tibia),  and 
occasionally  adjacent  to  the  lateral  malleolus  (the  protuberance  at  the 
lower end of the fibula); it has a shallow base with a flat margin and the 
surrounding skin has features of long standing venous hypertension, i.e. 
haemosiderin  pigmentation,  atrophie  blanche,  eczema,  and  dilated 
venules over the instep of the foot.
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Venous  ulcers  are  located  at  the severe  end of  the  spectrum of 
chronic venous disorders of the leg . Because of this they occur more 
often in subjects with other forms of venous diseases such as varicose 
veins  and  skin  changes.  Venous  leg  ulceration  has  been  reported  to 
account for 70-95% of all leg ulcers and 20-50% of these are said to be a 
consequence of varicose veins. However, there is a general lack of data 
explaining the way varicose veins develop into venous ulcers, and at what 
point  treatment  could  be  advised  as  being  prophylactic  rather  than 
remedial.
Venous hypertension is the undisputed initiating factor in venous 
ulcer  development. More severe venous incompetence is associated with 
a higher risk of  ulceration. The higher the venous pressure, the greater 
the risk, whether incompetence involves the deep or superficial venous 
system. The reasons why venous ulcers go on to develop is still an area of 
debate but there are three main theories .
An  important  determinant  of  venous  ulcers  is  the  venous 
hypertension that  can arise  after  deep vein thrombosis,  especially  if  it 
extends  above  the  knee.  Brandjes  et  al have  shown  that  wearing  a 
compression stocking can reduce the incidence of  the post-thrombotic 
limb. This condition commonly occurs after DVT; in the Brandjes study 
of DVT it occurred in 60% of the control arm within 2 years.
Events which cause venous ulceration - three theories
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• Fibrin cuff: Excessive venous pressure causes large molecules of 
fibrinogen  to  leak  out  into  superficial  tissues  because  capillary 
walls  are  only  one  epithelial  cell  thick.  Fibrinogen  is  then 
polymerised  into  fibrin  cuffs  around  capillaries,  which  prevents 
oxygen  and  nutrients  from  diffusing  out  from  the  capillaries, 
leading to cell death and ulceration. 
• White  cell  trapping: Venous  hypertension  causes  white  blood 
cells  to  become  trapped  and  accumulate  in  the  capillaries  of 
dependent  legs  (legs  which  are  allowed  to  hang  down  in  the 
dependent  position  for  long  periods).  This  leads  to  capillary 
occlusion, the release of protolyctic enzymes and toxic metabolites, 
which result in local ischaemia and ulceration. 
• A combination of mechanisms: A cascade of events is initiated 
by venous hypertension. White blood cells release cytokines which 
stimulate other cells to synthesise fibrin cuffs. These cuffs inhibit 
the  development  of  new  blood  vessels  and  deprive  superficial 
tissues  of  oxygen  and  nutrients,  leading  to  tissue  damage  and 
ulceration.
Risk factors
Risk factors for varicose veins include fixed factors - female sex, 
age, pregnancy, ethnicity, geographic location, left iliac vein compression 
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by  the  right  iliac  artery,  family  history  -  and  potentially  preventable 
factors - obesity, occupations requiring prolonged standing or sitting, lack 
of  dietary  fibre,  use  of  constricting  corsets  and  sitting  posture  for 
defecation
Sex
It is generally believed that women are more commonly affected 
by varicose veins  than men and most studies have shown a female 
predominance of varicose veins.
In the majority of studies the sex ratio decreases with increasing 
age. 
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Age
The association between age and prevalence of varicose veins is 
fairly conclusive. There is  a steady increase in prevalence of  varicose 
veins with increasing age for all grades of varicosity. The same trend was 
found in the prevalence of reticular and hyphenweb varices
Pregnancy
It is generally believed that pregnancy leads to varicose veins due 
to  the pressure  of  the  uterus  obstructing venous  return from the legs. 
However, this has been  refuted, as the majority of varices appear during 
the initial 3 months when the  uterus is not large enough. A hormonal 
factor is thought to be responsible or the increased circulating volume of 
blood.
Family history
A number of studies have found that the risk of varicose veins was 
higher  in  those  with  affected  relatives,  perhaps  suggesting  a  genetic 
element  or shared environmental  factors.  There is often a clear family 
history of the disorder with some patients inheriting abnormalities in the 
FOXC2 gene.
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Body weight and height
Several  studies  have  found  an  association  between  weight  and 
body  mass  and  an  increased  risk  for  varicose  veins.  there  was  an 
increased prevalence of varicose veins with increasing body weight
Occupation
A person's occupation is a possible risk factor for varicose  veins. 
A standing occupation has been indicated in some studies as a significant 
risk factor for varicose veins
OTHER RISK FACTORS
1. Smoking
2. Constricting undergarments
3. Post- thrombotic limb
4. Constipation
A diet deficient in fibre has been implicated as a major factor in the 
causation of  varicose veins. It is thought that fibre-depleted diets lead to 
constipation  and the  subsequent  straining  to  produce  a  stool  produces 
high intra-abdominal pressures which are transmitted to the leg veins and 
progressively dilate them.
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VARICOSITY OF GSV
HEALED VENOUS ULCER
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CLINICAL FEATURES :
- Asymptomatic
- aching in the calf particularly towards the end of the day
- pigmentation
- ankle swelling
- itching
- eczema
- venous ulceration
CLASSIFICATION AND GRADING
CEAP classification
Limbs  with  chronic  venous  disease  are  classified  according  to 
clinical  signs  (C),  cause  (E),  anatomic  distribution  (A),  and 
pathophysiologic condition (P)
Clinical classification                                                         
C0 : no visible or palpable signs of venous disease
C1 : telangiectasies or reticular veins
C2 : varicose veins
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C3 : edema
C4a : pigmentation or eczema
C4b : lipodermatosclerosis or atrophie blanche
C5 : healed venous ulcer
C6 : active venous ulcer
S : symptomatic, including ache, pain, tightness, skin irritation, 
heaviness, and muscle cramps, and other complaints 
attributable to venous dysfunction
A : asymptomatic
Etiologic classification
Ec: congenital
Ep: primary
Es: secondary (postthrombotic)
En: no venous cause identified
Anatomic classification
As: superficial veins
Ap: perforator veins
Ad: deep veins
An: no venous location identified
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Pathophysiologic classification
Basic CEAP
Pr: reflux
Po: obstruction
Pr,o: reflux and obstruction
Pn: no venous pathophysiology identifiable 
Venous Clinical Severity Score (VCSS)
Attribute Absent = 
0
Mild = 1 Moderate = 2 Severe = 3
Pain None Occasional Daily Limit activities
Varicose veins None Few, scattered Multiple (LSV) Extensive (LSV, 
SSV)
Venous edema None Evening, ankle Afternoon, leg Morning, leg
Pigmentation None Limited area Wide (lower 
1/3) 
Wider (above 
1/3)
Inflammation None Cellulitis Cellulitis Cellulitis
Induration None Focal (< 5 cm) < lower 1/3 Entire lower 1/3
Number of 
AC 
0 1 2 3
Duration of 
AC
None < 3 months 3 months – 1 
year
> 1 year
Size of AC None < 2 cm 
diameter
2-6 cm 
diameter
> 6 cm diameter
Comp therapy Not used Intermittent use Most days Continually
LSV, long saphenous vein; SSV, short saphenous vein; AC, active 
ulceration; lower 1/3, lower 1/3 of the leg.
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Venous Disability score (VDS)
Score Definition
0 Asymptomatic
1 Symptomatic, but able to carry out usual activities* with-out 
compressive therapy
2 Able to carry out usual activities* only with compression and/or 
limb elevation
3 Unable to carry out usual activities* even with compression 
and/or limb elevation
*Usual activities = patients activities before the onset of disability due to 
venous disease.
                                    
       
MANAGEMENT
INVESTIGATIONS
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Standard Doppler examination
A standard Doppler probe emits a sound when blood flows past the 
transmitting and receiving crystals. A uniphasic signal indicates flow in 
one direction. A biphasic signal indicates forward and reverse flowand is 
indicative  of  blood  refluxing  down  through  incompetent  valves.A 
Doppler probe is placed over the Saphenofemoral junction.A calf squeeze 
is  carried  out  and  if  a  biphasic  signal  is  obtained  this  confirms  the 
presence  of  incompetence  of  saphenofemoral  junction.This  is  not  an 
accurate method for establishing incompetence of the lesser  saphenous 
vein as  its  termination  is  variable  and it  is  difficult  to  separate  lesser 
saphenous  incompetence  from popliteal  valvular  incompetence.  In  all 
cases of short saphenous incompetence further investigation is desirable; 
this is usually carried out by duplex scanning
Duplex ultrasound imaging
The  probe  of  a  dulplex  scanner  contains  multiple  emitting  and 
receiving  crystals.  These  allow a  grey  scale  image  to  be  obtained  in 
which the veins are seen as a black void in the subcutaneous and deep 
tissues. Directional flow can be shown as a colour image (red or blue) 
superimposed on the grey scale image of the vessel. Visible venous flow 
can only be seen when augmented by a calf squeeze. The B-mode grey-
scale  image  allows  the  vein  to  be  traced  to  its  termination,while 
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compression and relaxation , or a Valsalva manoeuvre, may demonstrate 
the presence of retrograde flow.
Varicography
In  this  investigation  contrast  is  injected  directly  into  surface 
varices.  The contrast  is  non-thrombogenic,  as  it  is  non- ionic and iso-
osmolar with blood. This allows detailed mapping of the varices to their 
termination.This  is  an  extremely  useul  investigation  in  patients  with 
recurrent varicose veins or those with complex anatomy.
Venography
In this investigation tourniquets are used to direct contrast injected 
into the superficial veins of the foot into the deep veins of the calf, thigh 
and  pelvis.  It  is  not  used  as  a  standard  investigation  in  patients  with 
varicose  veins  but  is  useful  if  the  Duplex  scan  indicates  but  cannot 
confirm, the presence of post thrombotic change.
                                           TREATMENT 
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Current treatment options for venous disease include compression 
hosiery,   Sclerotherapy  (liquid  or  foam)  with  or  without  ultrasound 
guidance, endovenous  laser ablation treatment (EVLT), radiofrequency 
ablation, open surgery (usually sapheno-femoral ligation, stripping of the 
long  saphenous  vein  and  phlebectomies  or  sapheno-popliteal  ligation, 
and phlebectomies), and subfascial endoscopic perforator surgery alone 
or in  combination.
 Indications  for  interventions  include  recurrent  episodes  of 
haemorrhage and the development of skin changes(lipodermatosclerosis 
or  ulceration)  associated  with  an  ankle  flare  indicative  of  venous 
hypertension.
Patients should be treated with elastic compression stockings if the 
varicose  veins  are  found  to  be  associated  with  post  thrombotic 
damage.Most  patients  are  prescribed  class  II  stockings  with  an  ankle 
pressure of around 30mmHg decreasing to 10-15mmHg the knee level. 
Above – knee stocking should never be prescribed.Class I stockings can 
be used to control simple varicose veins.
Sclerotherapy
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During the last half of the 20th century, sclerotherapy as a major 
treatment  of   varicose  veins  came  and  went.  At  first,  it  was  widely 
heralded as a substitute for surgery but after a prospective randomized 
study by Hobbs,  interest  in  sclerotherapy waned.   In  this  technique  a 
detergent  is  injected directly  into the  superficial  veins.  The detergent 
destroys  lipid  membranes  of  endothelial  cells  causing  them  to  shed 
leading to thrombosis, fibrosis and obliteration( sclerosis).
Fegan  stressed  the  importance  of  continued  local  compression 
following sclerosant  injections to  reduce the incidence  and amount  of 
superficial thrombosis and improve the`sclerosis` of the vein . 
Foam sclerotherapy
Just  before  the  turn  of  the  21st  century,  Cabrera  published  his 
experience  with  foamed  sclerosant  in  patients  with  great  saphenous 
varices and arteriovenous malformations. Cabrera designed his treatment 
with the specific aim of obliterating the saphenous trunks. His technique 
consisted of  filling the great  saphenous vein in the thigh or  the small 
saphenous  vein  in  the  calf  with  foamed  sclerosant  injected  under 
ultrasound control. His initial report on long-term follow-up revealed that 
the results were at  least  comparable to surgery and perhaps somewhat 
better and his results have been confirmed by others. Investigations into 
treatment of small vein varices, including telangiectasias, has resulted in 
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the  finding that foam results in a 20% improved appearance compared to 
liquid sclerosant. The most popular sclerosants currently used as foams 
are polidocanol and sodium tetradecyl sulfate and of the many techniques 
used in  making foams,  the technique of Tessari has proven most popular
Foam sclerotherapy is a variant of sclerotherapy. It  differs  from 
liquid  sclerotherapy  in  that  instead  of  injecting  a  liquid  sclerosant 
solution into the  vein, the sclerosant is transformed into foam by forcibly 
mixing it with air or other type of gas.
Tessari developed an easy  way of making liquid sclerosant into 
foam using two syringes and a three-way stopcock
The foam solution has the consistency of  shaving cream, which 
improves treatment in two distinct ways. First, the foam displaces blood 
within the vein, permitting the full strength of the sclerosing agent to be 
in  direct  contact  with  the  vein  wall  for  an   extended  period  of  time 
without any dilution effects. Second, the foam is visible  via ultrasound 
imaging and can be easily tracked and guided to the source of the venous 
problem  The question arises of why foam sclerosant  treatment of CVI 
succeeds  when  liquid  sclerotherapy  treatment  of  CVI  has  made  little 
impact.  Foam improves  the  contact  with  the  endothelium of  the  vein 
compared to liquid sclerosants with an improved effect .The endpoint of 
TESSARI TECHNIQUE OF PRODUCING FOAM
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successful   sclerotherapy  is irreversible venous vascular fibrosis.  This 
only occurs in response to endothelial cell destruction with exposure of 
the  subendothelial  layer  of  cells.  This  is  accomplished  by  detergent 
sclerosants which work by the  mechanism of protein theft denaturation 
in which an aggregate of detergent  molecules forms a lipid bilayer in the 
form of a cylinder, a sheet or micelle. This  disrupts the endothelial cell 
surface by stealing away the essential proteins from  the cell membrane 
surface and producing delayed cell death.
Potential adverse events associated with sclerotherapy (liquid and 
foam)  include  allergy,  thrombophlebitis,  pigmentation,  nerve  damage, 
cutaneous necrosis, ulceration and matting. There are concerns that the 
sclerosant  can  potentially  enter  the  deep  veins  and  induce  venous 
thromboembolism.  There  are  additional  concerns  that,  particularly  in 
people with a Patent Foramen Ovale (PFO), the sclerosant may enter the 
arterial  circulation  and  induce  an  ischaemic  stroke  or   retinal  artery 
occlusion.  The  use  of  foam  may  increase  this  risk.  Transient  visual 
disturbances  are  reported  following  sclerotherapy.  The  mechanism  is 
uncertain  but  is  felt  to  be  vasospastic,  and  similarly  the  risk  may  be 
higher in foam compared with liquid sclerotherapy.
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Saphenofemoral junction ligation
An oblique incision is made in the groin centered 2.5 cm below and 
lateral   to  pubic  tubercle.  The greater  saphenous  vein is  found in  the 
superficial fat by blunt dissection and traced upwards to its `T` shaped 
termination  with  the  Femoral  vein.  This  must  be  clearly  established 
before the vein is divided.As the vein is  traced to its  termination four 
tributaries  are  normally  encountered.  These  are  the superficial  inferior 
epigastric  vein,the  superficial  circumflex  iliac  vein  and  the  deep  and 
superficial  external  pudendal  veins.The  long  saphenous  veinis  not 
ligateduntil the T-junction has been confirmed and the femoral vein has 
been exposed for a centimeter in either direction
Greater saphenenous stripping
The saphenous trunk is retrogradely stripped to the knee. Either a 
variation  of   Babcock`s  intraluminal  stripper  or  a  rigid  metal  `pin` 
stripper  is  used  which  invaginates  the  vein  and  causes  less  bruising. 
Stripping not  only  avulses  the main  vein trunk but  also  pulls  out  the 
termination of the tributaries
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SAPHENOFEMORAL JUNCTION LIGATION 
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GSV STRIPPING
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Radiofrequency ablation
In this technique a catheter is passed up the saphenous vein from 
the  lower  leg  and  withdrawn  under  ultrasound  control  while 
radiofrequency waves are  used to destroy the endothelial lining through a 
series of metal prongs. 
Endovenous laser ablation
It is a more recent development. A laser probe is passed up inside a 
catheter   inserted  into  the  lowerpart  of  the  saphenous  vein  under 
ultrasound guidance.  It  is   important  that  large amounts  of  crystalline 
fluid containing local anaestheic are  placed around the vein to seperate 
the skin from the laser probe and avoid cutaneous burns. The laser probe 
is  withdrawn from the sapheno femoral  junction ,  administering  a  set 
number of joules to the endothelial lining of the saphenous  vein. The 
laser probes are marginally less expensive than radiofrequency ablation.
Both  laser  and  RFA  do  not  provide  `flush`  occlusion  of  the 
saphenous vein, often leaving tributaries that would always be divided at 
surgery. Long term  studies are required to ascertain the recurrence rate of 
both techniques.  
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Subfascial endoscopic perforator vein surgery
Preoperative evaluation  is  performed  by duplex  scanning of  the 
superficial, deep and perforator venous systems to diagnose both valvular 
incompetence and obstruction. Standard laparoscopic equipment is used. 
At  operation  the  limb  is  exsanguinated,  and  two  endoscopic  ports 
(typically a 10 mm and a 5 mm port) are placed in the subfascial space in 
the calf at two sites remote from the area of venous ulceration. A space-
maker  balloon  is  introduced  and  inflated  in  this  subfascial  space  to 
improve access. Carbon dioxide is then insufflated to facilitate dissection. 
The  incompetent  perforating  veins  are  clipped  and  divided  using 
endoscopic  scissors  or  alternatively,  coagulated  and  divided  using  an 
ultrasonic coagulator (harmonic scalpel). 
45
REVIEW OF LITERATURE
1. Bountouroglou DG   et al (Eur J Vasc Endovasc Surg, Jan 2006 ) 
Conducted a   prospective randomised controlled trial  comparing 
sapheno-femoral  ligation, great saphenous stripping and multiple 
avulsions  with  sapheno-femoral  ligation  and  ultrasound  guided 
foam sclerotherapy to the saphenous vein. Primary end points were 
patient recovery period and quality of life and secondary end points 
frequency of complications on the two arms of the trial and the cost 
of  the treatment.  Sixty  patients  were included in the trial.  They 
concluded that   Ultrasound guided sclerotherapy  combined  with 
sapheno-femoral  ligation  was  less  expensive,  involved a  shorter 
treatment time and resulted in more rapid recovery compared to 
sapheno-femoral ligation, saphenous stripping and  phlebectomies.
2. Rabe .E, Otto. J(Eur J Vasc Endovasc Surg.feb 2008)  Compared 
standardised  polidocanol  foam  to  liquid  polidocanol  in  a 
randomized  controlled  trial.  106  patients  with  primary  varicose 
veins  due  to  an   incompetent  GSV  were  treated  with  either 
standardised 3% polidocanol foam or 3% liquid polidocanol. The 
primary  efficacy  criterion  was  elimination  of  reflux  (<0.5  sec) 
measured 
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3. cm  below  the  sapheno-femoral  junction  (SFJ)  by  duplex 
ultrasonography  3  months  after  the  last  injection.  The  results 
showed  that  a  significantly  greater  number  of  patients  were 
successfully  treated  by  foam  sclerotherapy  resulting  in  69% 
elimination of reflux compared to 27% patients treated with liquid 
sclerosant Abela.R et al( Eur J Vasc Endovasc surg . Oct 2008) 
Compared   Reverse  Foam Sclerotherapy of  the great  saphenous 
vein  (GSV)   combined  with  sapheno-femoral  junction  (SFJ) 
ligation  to  standard  (Babcock)  stripping  and  invagination  (Pin) 
stripping in a prospective  clinical series. They found that standard 
stripping of the GSV and  invagination stripping are not associated 
with major  discomfort  and  problems in the early post-operative 
period. SFJ ligation and GSV  reverse foam sclerotherapy yielded 
greater  patient  satisfaction  with   less  post-op  bruising  and 
discomfort and reduced analgesic  requirements
4. Rutgers.  PH,  Kitslaar.  PJ(Am  J  Surg  Oct  1994)  compared  the 
treatment of greater saphenous vein insufficiency by  stripping and 
local  avulsions  of  varicose  veins  with  high  ligation  of  the 
saphenofemoral  junction  (crossectomy)  combined  with 
sclerocompression  therapy.  Of  156 consecutive  patients,  89 legs 
were  randomly allocated to stripping and 92 to high ligation. At 
47
follow-up of 3 months and 1, 2, and 3 years after treatment, clinical 
and  Doppler  ultrasound  results,  and  complaints  and  cosmetic 
results, as judged by  the patient and the surgeon, were scored. The 
results  of  treatment  of  isolated  saphenous  vein  insufficiency  by 
stripping operation, therefore, were superior to those obtained by 
high ligation combined with sclerotherapy.
5. Miyazaki K et al (Int Angiol Sep 2005) Determined the long-term 
recurrence  rates  of  greater  saphenous  vein  (GSV)  insufficiency 
after  treatments  for  primary  varicose  veins.  The 
recurrence  -  free  rates  after  stripping  surgery,  saphenofemoral 
ligation,  and  sclerotherapy  were  estimated.  The  saphenofemoral 
ligation  group  and  sclerotherapy  group  had  significantly  higher 
recurrence rates than  the stripping group. There was no difference 
in recurrence rates between the saphenofemoral ligation group and 
sclerotherapy group
6. Yamaki  T,  Nozaki  M  (Eur  J  Vasc  Endovasc  surg   Oct  200 
Compared  the proportion of foam sclerosant that enters deep veins 
between multiple injections of <0.5ml foam per injection and a few 
injections of >0.5ml foam per injection. One hundred and seven 
patients with superficial venous incompetence were randomised to 
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receive either multiple injections of <0.5ml 1% polidocanol (POL) 
foam (multiple injections) or a few injections of >0.5ml 1% POL 
foam per injection (few injections)  for  the treatment  of  varicose 
tributaries.  These  findings  suggest  that  multiple  small-dose 
injections can reduce the amount of foam sclerosant and the risk of 
foam sclerosant entering the deep veins in patients with superficial 
venous insufficiency.  
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MATERIALS AND METHODS
This is a prospective randomized study conducted at Government 
Rajaji Hospital, attached to Madurai Medical College, Madurai, from the 
year 2006-2007.
           
After  obtaining  approval  by  the  ethics  committee  and  informed 
consent, a total of 50 patients of either gender with varicose veins of the 
lower limbs , including those with venous ulcers were enrolled for this 
study.  Patients  with  recurrent  varicose  veins  ,  multiple  perforator 
incompetence, allergy to sclerosant and history of deep vein thrombosis 
were excluded from the study. 
        
All  patients  underwent  Doppler  scanning  to  identify 
Saphenofemoral incompetence, the sites of incompetent perforators and 
to rule out deep vein thrombosis. The patients were randomly allocated to 
one of the two groups
           
            Group 1 : SF ligation with foam sclerotherapy
            Group 2 : SF ligation and stripping
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Sixty  patients  with  primary  varicose  veins  due  to  GSV 
incompetence and suitable for day care surgery were randomly allocated 
to  undergo  ultrasound-guided  sclerotherapy  with  sapheno-femoral 
ligation  under  local  anaesthesia  (n=25)  or  sapheno-femoral  ligation, 
stripping and multiple  avulsions  under  general  or  regional  anaesthesia 
(n=25).  The  study  protocol  included  history,  physical  examination, 
assignment of CEAP class and assessment venous clinical severity score 
(VCSS),  and colour duplex ultrasound to identify sites of incompetent 
perforators and to rule out deep vein thrombosis.
PREPARATION OF FOAM:
The Tessari technique was used to convert liquid sclerosant ( 3% 
sodium tetradecyl sulphate) to foam. Two 5cc syringes are connected by 
a three-way valve and the fluid sclerosant is forcibly mixed with air at a 
ratio of  liquid: air of 1:4 and frothed into foam by a pumping action.
TECHNIQUE OF SCLEROTHERAPY:
Sclerotherapy was conducted as an outpatient  procedure without 
anaesthesia.The  vein  was  cannulated  at  the  ankle  with   a  scalp  vein 
needle and foam injected.
Duplex  ultrasound  imaging  was  used  to   guide  cannulation, 
monitor the injection and flow of foam and to minimise the risk of foam 
51
diffusion to the deep venous  system. More than one injection was used 
during the same session in an attempt to ensure that all of the target veins 
have been completely  filled. Localised compression with the ultrasound 
probe was applied over the  main sites of communication between the 
superficial  and  deep  venous  systems  i.e  sapheno-femoral,  sapheno-
popliteal junction,and perforators when truncal veins were injected, with 
the aim of avoiding entry of sclerosant into the deep veins.
The limb was held elevated at an angle of 45º and compression at 
the sites of communication applied for a period  of  5 min. Elastocrepe 
bandages were applied to maintain compression and patient was advised 
strict bed rest for a period of  6 hrs. A maximum of 10ml of foam was 
used in a session. More than one treatment session was used in case of 
extensive varicosities. 
Sapheno-femoral ligation was done under local anaesthesia  after a 
period of  2 days.
Patients in the control group underwent Sapheno- femoral ligation , 
stripping and multiple avulsions under general or regional  anaesthesia.
Patients in both groups were followed up for a period of 1 yr and 
compared for the following parameters
1. Procedure time
2. Perioperative complications
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3. Complete occlusion of treated veins (by Duplex scanning at 3 
months)
4. Healing of venous ulceration
5. Quality of life such as time to return to normal activity, symptom 
relief, and change of disease severity measured by CEAP score
6. Recurrence of varicose  veins
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FOAM INJECTION UNDER USG GUIDANCE 
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FOAM IN GSV
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OBSERVATION AND RESULTS
A. Characteristics of cases studied
Table 1 : Age
Age group
Group 1- SF ligation+ 
Foam sclerotherapy
Group 2- SF ligation 
+stripping
No % No %
31 -  40 4 16 6 24
41 – 50 10 23.3 8 23.3
51 – 60 8 16.7 8 23.3
61 – 70 3 10.0 3 10.0
Total 25 100 25 100
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AGE DISTRIBUTION 
Table 2 : Sex
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Sex
Group 1- SF ligation + 
Foam sclerotherapy
Group 2 – SF ligation 
+ stripping
No % No %
Males 27 90 28 93.3
Females 3 10 2 6.7
The demographic data of the patients included in this study showed no
 significant difference between both groups in terms of age and sex
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SEX DISTRIBUTION 
59
Table 3: Procedure time
Procedure time
Group  1  –  SF 
Ligation  +  foam 
sclerotherapy
Group  2  -  SF 
Ligation +stripping
No. % No %
36- 45 min 19 76 3 12
46- 55 min
      4 16      12 48
56- 65 min 2 8 9 36
66-75 min - 1 4
The  time  taken  to  complete  treatment  was  shorter  in  the  foam 
sclerotherapy plus SFJ ligation group: 40 vs. 55 min 
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Table 4: Healing of ulcer
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Ulcer healing
Group 1-
SF ligation + foam 
sclerotherapy
Group 2-
SF ligation +stripping
No. % No. %
Healed          6      85.7       6       75
Residual ulcer         1      14.3       2       25
                
The rate of longer-term (>30 days) ulcer healing rate in the case 
series ranged from 75 to 85%. 6 (85.7%) of 7 ulcers healed in the foam 
sclerotherapy group compared with 6 (75%) of 8 in the SF ligation and 
stripping group
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Table 5: Quality of life ( CEAP score change)
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C  score 
improved by
Group 1-
SF ligation + Foam 
sclerotherapy
Group 2 – SF ligation 
+stripping
No.
% No. %
      1       1      4         2        8
      2       7     28        9       36
      3      15     60       13       52
      4      2      8        1       4
At  3  months,  median  CEAP  class  dropped  from  four  pre-
operatively  to one following treatment in both groups
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Table 6: Recurrence at 1 yr
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Recurrence
Group 1 – SF 
ligation+ Foam 
sclerotherapy
Group 2 – SF 
ligation + stripping
No. % No. %
Present          1     4          -      0
Absent         24      96        25     100
1 patient  out  of  25 treated by foam sclerotherapy reported venous 
recanalisation at one year after  treatment. There was no recurrence in the 
group that underwent stripping and multiple phlebectomies.
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Table 6: Time to return to normal activity
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Time in 
days
Group 1 – SF ligation+ 
Foam sclerotherapy
Group 2 – SF 
ligation + stripping
No. % No. %
      2-3        1    4          -      0
      4-5        12    48         2      8
      6-7        8    32        3      12
      8- 9        4    16       17      68
    10-11        -    0        3      12
Median  time  to  return  to  normal  activities  was  significantly 
reduced  in   the  foam  sclerotherapy  group  (4  days)  compared  to  the 
surgical group (9 days)
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RECOVERY TIME
Table 7: Complications in Foam sclerotherapy
Complications in Foam 
sclerotherapy
No. %
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Skin ulceration               2              8
Pain at injection site
             
              7
           
             28
Pigmentation
             
              2
             
              8
Thrombophlebitis
           
              4
           
             16
Coughing &chest tightness
           
              1
             
               4
Local  adverse  events  were  relatively  common.  Rates  of 
thrombophlebitis was  16%.skin staining/pigmentation at 8%, and pain at 
the  site  of  injection  ranged  was  28%.   There  were  no  systemic 
complications  except  for  a  patient  with  transient  cough  and  chest 
tightness.No serious adverse events associated with foam sclerotherapy, 
including arterial  events  like  stroke and myocardial infarction, grand 
mal epileptic fit,  pulmonary embolism, and deep vein thrombosis were 
encountered
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VARICOSITY OF GSV
71
HEALED VENOUS ULCER
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DISCUSSION
Significant  advances  have  occurred  in  the  understanding, 
diagnosis, and  management of venous insufficiency over the last decade 
or so, mostly owing to the use of duplex ultrasound (DUS) technology. 
Stripping  of  the  great  saphenous  vein  (GSV)  has  been  widely  agreed 
upon  as  essential  to  minimizing  recurrence  due  to  redevelopment  of 
incompetent communication with the sapheno femoral confluence and/or 
thigh perforator incompetence. Stripping of the vein requires additional 
incisions at  the knee or  below the knee and is associated  with a high 
prevalence  of  minor  surgical  complications.  Avulsion  phlebectomy 
requires multiple 2- to 3-mm incisions along the course of the vein and 
can cause damage to adjacent nerves and lymphatic vessels.
Sclerotherapy  with  liquid  sclerosant  was  introduced  as  an 
alternative to surgery but was soon abandoned as a result of  high failure 
rates , frequent recurrence and unacceptably high rates of complications 
due to the large volume of sclerosant required.
Foam sclerotherapy which has gained popularity in the last decade 
and has been evaluated in this study as an alternative to  stripping of 
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varicose veins. Converting the sclerosant to foam has served to reduce the 
dose of sclerosant and also increased its efficacy 
In this study there was no significant difference in the median age 
and sex ratio in the case and contol groups. In the present series the time 
required  for  foam  sclerotherapy  and  Sapheno  femoral  ligation  was 
significantly  less  than  that  required  for  Sapheno  femoral  ligation, 
stripping and multiple phlebectomies.
 Bountouroglou  reported  data  on  operation  time  (foam 
sclerotherapy plus ligation  was 45 minutes versus 85 minutes for ligation 
plus stripping plus avulsion). The foam sclerotherapy was combined with 
sapheno-femoral junction ligation. this  goes well with the present series.
Three  case  series  involving  216  patients  and  two  case  reports 
involving three patients reported data on healing of venous ulcers.  All 
studies  used polidocanol foam. The  ulcer healing rate in the case series 
ranged from 76.4% to 100% .In is study Sodium Tetra decyl sulphate was 
the sclerosant used and showed healing rates of 85%. It is unclear if the 
better    healing rate can be atitributed to the sclerosant used.
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Majority  of  patients  in  both  groups  in  our  series  showed 
improvement  in  the  quality  of  life  (measured  by  the  CEAP  score) 
compared  to  baseline,  however  there  was  no  significant  difference 
between the two groups , showing that both were equally efficacious.
A RCT by Hamel-Desnos C, involving 45 patients treated by foam 
sclerotherapy reported venous recanalisation at one year after treatment, 
with a rate of 4.4%. This was lower than that in the liquid sclerotherapy 
group but  not  statistically  significant  (relative risk 0.5,  95% CI 0.1 to 
2.5). 
One non-randomised comparative study by Yamaki T involving 37 
patients treated by foam sclerotherapy reported venous disease recurrence 
also at one year after treatment, with a rate of 8.1%, which was also lower 
than that in the liquid sclerotherapy group. In the present series 1 out of 
25 (4%) patients showed  recurrence at  1 yr.
Bountouroglou DG et al, in their study found that the median time 
required to  return to  normal  activity  following surgery  (13  days)  was 
significantly  higher  compared  to  those  who  underwent  foam 
sclerotherapy (2days). This correlates well with our series in which most 
patients recovered in 8 days following surgery and in 2 days following 
foam sclerotherapy.
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‘Minor’  vein  thrombosis  (rates  ranged  from  0  to  17.6%), 
thombophlebitis  (rates  ranged  from  0  to  45.8%),  and  skin 
matting/pigmentation/staining  (rates  ranged  from  0  to  66.7%),  were 
relatively common occurrences and their incidence  was similar to those 
in comparator  groups,  other  than in one RCT where the risk  of  skin 
matting/pigmentation/staining  was  significantly  higher  for  foam 
sclerotherapy compared with surgery. Pain provoked by injection or long-
term  pain localised at the area sclerosed was reported as ranging from 0.6 
to 41.0%. 
Arterial events, particularly stroke and myocardial infarction (MI), 
can be life threatening.  One case of stroke was reported One possible 
explanation for arterial events is the existence of a Patent Foramen Ovale 
(PFO), especially with right-to-left shunt. 
In our series the commonest complication encountered was pain at 
site  of injection at  28% and thrombophlebitis  (16%) followed by skin 
ulceration and pigmentation(8%).
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CONCLUSION
To conclude, treatment of varicose veins with Foam sclerotherapy 
and  saphenofemoral ligation  or Saphenofemoral ligation and stripping 
provide  similar  results,  but  the  use  of  Foam sclerotherapy  instead  of 
stripping and avulsions reduces the operative and post operative recovery 
time. 
Sclerotherapy  obviates the need for general anaesthesia  and hence 
can be used in patients who are poor candidates for surgery.
The  short  period  of  follow  up  in  this  study  is  insufficient  for 
observing  longerterm  efficacy.  Though  this  study  has  established  the 
safety  of   Foam sclerotherapy further  studies  with a  longer  follow-up 
period , are required to  determine the comparative effectiveness of foam 
sclerotherapy and its optimal place in clinical practice.
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S.N
o NAME
AG
E
SE
X
I.P 
NO
PROCEU
RE 
TIME
ULCER 
HEALING
CEAP 
SCORE 
CHANGE
RECURRE
NCE
RECOVE
RY
 TIME COMPLICATIONS
1   CHANDRAN 41 M
45923
5 35  NO ULCER 3 NO 4 NIL
2   MUTHURAJ 54 M
41383
2 38  NO ULCER 2 NO 6
THROMBOPHLEBITIS + 
PAIN
3
  MAHALINGA
M 31 M
46393
5 40  NO ULCER 3 NO 7 NIL
4   PAPPAIAH 42 M
49190
0 45  HEALED 2 NO 9 PAIN
5   SAKTHIVEL 42 M
49918
7 50  NO ULCER 2 NO 6 PAIN
6   GOVINDAN 35 M
51249
5 42  NO ULCER 3 NO 7 PIGMENTATION
7   MARIAMMAL 38 F
51874
1 37  NO ULCER 3 NO 2 NIL
8   SUBRAMANI 41 M
52617
9 56  HEALED 4 NO 6 NIL
9   RAMU 55 M
52925
7 38  NO ULCER 3 NO 8
SKIN 
ULCERATION+PAIN
10
  SHANMUGA
M 61 M
53249
6 36  NO ULCER 2 NO 5 NIL
11   RAVI 39 M
53532
0 39  NO ULCER 3 NO 7 PAIN
12
  KARTHIKEY
AN 43 M
53580
6 40  NO ULCER 3 NO 6 THROMBOPHLEBITIS
13   PONNUTHAI 52 F
54255
0 48
 RESIDUAL 
ULCER 1 NO 4 NIL
14   SIVANADI 63 M
54323
6 39  NO ULCER 3 NO 4 NIL
80
15   SAKTHIVEL 41 M
54392
0 40  NO ULCER 3 NO 6
THROMBOPHLEBITIS 
=+ PAIN
16
  POTHUMPO
NNU 56 F
54527
3 42  HEALED 3 NO 4 NIL
17   PERUMAL 46 M
54586
3 36  HEALED 4 NO 4 NIL
18   PITCHAI 63 M
54837
5 38  NO ULCER 3 NO 9
SKIN 
ULCERATION+PAIN
19   PANDIAN 45 M
54864
9 40  NO ULCER 2 YES 4 NIL
20   RAMAR 55 M
54927
7 50  HEALED 3 NO 5 PIGMENTATION
21   VELLAISAMY 57 M
54932
9 43  NO ULCER 2 NO 4 NIL
22
  MURUGESA
N 53 M
55062
0 46  HEALED 2 NO 8 THROMBOPHLEBITIS
23
  MARIYAPPA
N 45 M
58813
2 40  NO ULCER 3 NO 4 NIL
24
  MUTHUMAY
AN 56 M
57845
6 37  NO ULCER 3 NO 4 NIL
25
  RAHEEM 
BASHA 42 M
57856
2 38  NO ULCER 3 NO 4 NIL
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CEAP 
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 TIME
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1
  ABDUL 
KADHAR 45 M 459235 48  NO ULCER 2  NIL 8
2   DHARMARAJ 53 M 463935 55  HEALED 3  NIL 9
3
  ALEXPANDIA
N 34 M 413832 57  NO ULCER 2  NIL 6
4   DEVARAJ 55 M 482888 60  NO ULCER 3  NIL 9
5
  VARADHARA
JAN 63 M 486200 55  NO ULCER 3  NIL 9
6   SOLAI 57 M 488215 60  HEALED 2  NIL 11
7   KANNAN 45 M 493534 53  HEALED 2  NIL 8
8   VELU 56 M 491877 54
 RESIDUAL 
ULCER 1  NIL 10
9   RAKKU 36 F 513209 40  NO ULCER 3  NIL 7
10   ANTONY 43 M 513247 52  NO ULCER 3  NIL 8
11   MUTHUSAMY 61 M 526320 63  NO ULCER 2  NIL 9
12   RATHINAM 35 M 516212 55  HEALED 3  NIL 8
13   MUNIYANDI 55 M 539391 64  NO ULCER 3  NIL 7
14   PUSHPAM 47 F 541543 49  NO ULCER 2  NIL 9
15   MURUGAN 52 M 541552 58  HEALED 3  NIL 8
16
  MARIYAPPA
N 55 M 541749 70  NO ULCER 3  NIL 9
17   RAJKUMAR 35 M 545260 48  HEALED 4  NIL 4
18
  PANDIARAJA
N 45 M 548738 57  NO ULCER 2  NIL 8
19   SOLAIMALAI 31 M 550545 55  NO ULCER 3  NIL 9
20   MUSTAFA 62 M 552026 48  NO ULCER 3  NIL 5
21
  MUTHUPAND
I 52 M 552823 42
 RESIDUAL 
ULCER 1  NIL 10
22   MANI 48 M 553272 60  NO ULCER 2  NIL 8
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23
  PALANIKUMA
R 37 M 553603 45  NO ULCER 2  NIL 8
24
  SELVAKUMA
R 45 M 553889 55  NO ULCER 3  NIL 9
25   SEKARAN 41 M 554121 58  NO ULCER 3  NIL 9
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